Cited by 2,010MicroRNA in disease regulationCancer-related Molecular PathwaysCancer-related molecular mechanisms research

The DOI matches its Crossref record; 55 of the 59 references it cites were found in a registry or an index.

Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes Apoptosis

Open access

Chang, Tsung-Cheng, Wentzel, Erik A., Kent, Oliver A., Ramachandran, Kalyani, Mullendore, Michael, Lee, Kwang Hyuck, Feldmann, Georg, Yamakuchi, Munekazu, Ferlito, Marcella, Lowenstein, Charles J., Arking, Dan E., Beer, Michael A., Maitra, Anirban, Mendell, Joshua T.·2007·Molecular Cell

DOI 10.1016/j.molcel.2007.05.010PMC PMC1939978

Open this paper in CoChat — free account Open PDF

Abstract

The p53 tumor suppressor protein is a critical regulator of the cellular response to cancer-initiating insults such as genotoxic stress. In this report, we demonstrate that microRNAs (miRNAs) are important components of the p53 transcriptional network. Global miRNA expression analyses identified a cohort of miRNAs that exhibit p53-dependent upregulation following DNA damage. One such miRNA, miR-34a, is commonly deleted in human cancers and, as shown here, frequently absent in pancreatic cancer cells. Characterization of the miR-34a primary transcript and promoter demonstrates that this miRNA is directly transactivated by p53. Expression of miR-34a causes dramatic reprogramming of gene expression and promotes apoptosis. Much like the known set of p53-regulated genes, miR-34a-responsive genes are highly enriched for those that regulate cell-cycle progression, apoptosis, DNA repair, and angiogenesis. Therefore, it is likely that an important function of miR-34a is the modulation and fine-tuning of the gene expression program initiated by p53.

Integrity signals

Registry

Crossref · 10.1016/j.molcel.2007.05.010

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Untitled work
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Gentleman R: R: A language for data analysis and graphics
Ihaka, R., & Gentleman, R. (1996) · Journal of Computational and Graphical Statistics · doi:10.1080/10618600.1996.10474713 · Cited by 11,747
The functions of animal microRNAs
Ambros, V. (2004) · Nature · doi:10.1038/nature02871 · Cited by 10,728
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
DAVID: Database for Annotation, Visualization, and Integrated Discovery
Dennis, G., Sherman, B. T., Hosack, D. A., Yang, J., Gao, W., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-5-p3 · Cited by 9,327
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,328
MicroRNA signatures in human cancers
Calin, G. A., & Croce, C. M. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1997 · Cited by 7,668
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Surfing the p53 network
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884

Flagged first, then by citations

Show all 59 references

4 of the 59 references couldn’t be matched to a known paper.

Sorted by citations

Items 701–800 of 1,000

Sirtuin 1 (SIRT1) Deacetylase Activity and NAD+/NADH Ratio Are Imperative for Capsaicin-Mediated Programmed Cell Death
Lee, Y., Chen, H.-Y., Su, L. J., & Chueh, P. J. (2015) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5b02876 · Cited by 59
miRNA‐34a promotes proliferation of human pulmonary artery smooth muscle cells by targeting PDGFRA
Wang, P., Xu, J., Hou, Z.-L., Wang, F., Song, Y., Wang, J., Zhu, H. F., & Jin, H. (2016) · Cell Proliferation · doi:10.1111/cpr.12265 · Cited by 62
Co-Delivery Nanosystems for Cancer Treatment: A Review
Eftekhari, R. B., Maghsoudnia, N., Samimi, S., Zamzami, A., & Dorkoosh, F. A. (2019) · Pharmaceutical Nanotechnology · doi:10.2174/2211738507666190321112237 · Cited by 65
MicroRNAs in osteosarcoma: From biological players to clinical contributors, a review
Zhou, G., Shi, X., Zhang, J., Wu, S., & Zhao, J. (2013) · Journal of International Medical Research · doi:10.1177/0300060513475959 · Cited by 61
Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer
Mahdian-shakib, A., Dorostkar, R., Tat, M., Hashemzadeh, M. S., & Saidi, N. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.09.087 · Cited by 61
Development and progression of colorectal neoplasia
Manne, U., Shanmugam, C., Katkoori, V. R., Bumpers, H. L., & Grizzle, W. E. (2011) · Cancer Biomarkers · doi:10.3233/cbm-2011-0160 · Cited by 68
MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer
Chen, X., Dong, C., Law, P. T. Y., Chan, M. T. V., Su, Z., Wang, S., Wu, W. K. K., & Xu, H. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.10.008 · Cited by 61
Role of microRNA deregulation in the pathogenesis of diffuse large B-cell lymphoma (DLBCL)
Mazan-Mamczarz, K., & Gartenhaus, R. B. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.08.020 · Cited by 61
MicroRNAs in colorectal cancer: Function, dysregulation and potential as novel biomarkers
Nugent, M., Miller, N., & Kerin, M. J. (2011) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2011.05.005 · Cited by 61
Increased MicroRNA-34b and -34c Predominantly Expressed in Stromal Tissues Is Associated with Poor Prognosis in Human Colon Cancer
Hiyoshi, Y., Schetter, A. J., Okayama, H., Inamura, K., Anami, K., Nguyen, G. H., Horikawa, I., Hawkes, J. E., Bowman, E. D., Leung, S. Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124899 · Cited by 61
Kallistatin induces breast cancer cell apoptosis and autophagy by modulating Wnt signaling and microRNA synthesis
Li, P., Guo, Y., Bledsoe, G., Yang, Z., Chao, L., & Chao, J. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.01.004 · Cited by 62
Life and Death Decision-Making by p53 and Implications for Cancer Immunotherapy
Liu, Y. U., Leslie, P. L., & Zhang, Y. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.10.005 · Cited by 61
Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment
Raue, R., Frank, A.-C., Syed, S. N., & Brüne, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042210 · Cited by 63
5-Aminolevulinic acid-mediated sonodynamic therapy induces anti-tumor effects in malignant melanoma via p53-miR-34a-Sirt1 axis
Hu, Z., Fan, H., Lv, G., Zhou, Q., Yang, B., Zheng, J., & Cao, W. (2015) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2015.04.010 · Cited by 60
The interplay of microRNA and neuronal activity in health and disease
Eacker, S. M., Dawson, T. M., & Dawson, V. L. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00136 · Cited by 63
MiR-433 and miR-127 Arise from Independent Overlapping Primary Transcripts Encoded by the miR-433-127 Locus
Song, G., & Wang, L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003574 · Cited by 60
The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis
Domingo-Fernandéz, R., Watters, K. M., Piskareva, O., Stallings, R. L., & Bray, I. M. (2012) · Pediatric Surgery International · doi:10.1007/s00383-012-3239-7 · Cited by 61
MicroRNA regulation and dysregulation in epilepsy
Dogini, D. B., Avansini, S. H., Vieira, A. S., & Lopes‐Cendes, Í. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00172 · Cited by 60
MicroRNA‐34/449 controls mitotic spindle orientation during mammalian cortex development
Fededa, J. P., Esk, C., Mierzwa, B. E., Stanytė, R., Yuan, S., Zheng, H., Ebnet, K., Yan, W., Knoblich, J. A., & Gerlich, D. W. (2016) · The EMBO Journal · doi:10.15252/embj.201694056 · Cited by 62
The miR-34a-5p promotes the multi-chemoresistance of osteosarcoma via repression of the AGTR1 gene
Pu, Y., Zhao, F., Li, Y., Cui, M., Wang, H., Meng, X., & Cai, S. (2017) · BMC Cancer · doi:10.1186/s12885-016-3002-x · Cited by 60
Regulating the regulators: Epigenetic, transcriptional, and post-translational regulation of RGS proteins
Alqinyah, M., & Hooks, S. B. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.10.007 · Cited by 60
Association between genetic variants in pre-miRNA and colorectal cancer risk in a Chinese population
Lv, M., Dong, W., Li, L., Zhang, L., Su, X., Wang, L., Gao, L., & Zhang, L. (2013) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-013-1456-7 · Cited by 59
Soy Isoflavone Genistein Impedes Cancer Stemness and Mesenchymal Transition in Head and Neck Cancer through Activating miR-34a/RTCB Axis
Hsieh, P., Liao, Y., Hsieh, C.-W., Chen, P., & Yu, C. (2020) · Nutrients · doi:10.3390/nu12071924 · Cited by 63
TP53-independent Function of miR-34a via HDAC1 and p21CIP1/WAF1
Zhao, J. Y., Lammers, P., Torrance, C. J., & Bader, A. G. (2013) · Molecular Therapy · doi:10.1038/mt.2013.148 · Cited by 62
Methylation-associated silencing of microRNA-34b in hepatocellular carcinoma cancer
Xie, K., Liu, J., Chen, J., Dong, J., Ma, H., Liu, Y., & Hu, Z. (2014) · Gene · doi:10.1016/j.gene.2014.03.059 · Cited by 59
MicroRNA (miRNA)-mediated Interaction between Leukemia/Lymphoma-related Factor (LRF) and Alternative Splicing Factor/Splicing Factor 2 (ASF/SF2) Affects Mouse Embryonic Fibroblast Senescence and Apoptosis
Verduci, L., Simili, M., Rizzo, M., Mercatanti, A., Evangelista, M., Mariani, L., Rainaldi, G., & Pitto, L. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.114736 · Cited by 58
MicroRNAs as biomarkers of cervical cancer development: a literature review on miR-125b and miR-34a
Ribeiro, J., & de Sousa, H. M. L. (2014) · Molecular Biology Reports · doi:10.1007/s11033-013-2998-0 · Cited by 61
MicroRNA-224 Negatively Regulates p21 Expression During Late Neoplastic Progression in Inflammatory Bowel Disease
Olaru, A., Yamanaka, S., Vazquez, C., Mori, Y., Cheng, Y., Abraham, J. M., Bayless, T. M., Harpaz, N., Selaru, F. M., & Meltzer, S. J. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e31827e78eb · Cited by 59
The Role of Bioactive Dietary Components in Modulating miRNA Expression in Colorectal Cancer
Gavrilaș, L. I., Ionescu, C. M. L., Tudoran, O. M., Lisencu, C. I., Bălăcescu, O., & Miere, D. (2016) · Nutrients · doi:10.3390/nu8100590 · Cited by 61
IFITM1 suppression blocks proliferation and invasion of aromatase inhibitor-resistant breast cancer in vivo by JAK/STAT-mediated induction of p21
Lui, A. J., Geanes, E. S., Ogony, J. W., Behbod, F., Marquess, J., Valdez, K. E., Jewell, W. R., Tawfik, O. W., & Lewis-Wambi, J. S. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.04.005 · Cited by 59
The Crosstalk of miRNA and Oxidative Stress in the Liver: From Physiology to Pathology and Clinical Implications
Klieser, E., Mayr, C., Kiesslich, T., Wissniowski, T., Fazio, P. D., Neureiter, D., & Ocker, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215266 · Cited by 59
Structural and Functional Regulation of Lactate dehydrogenase-A in Cancer
Woodford, M. R., Chen, V. Z., Backe, S. J., Bratslavsky, G., & Mollapour, M. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0287 · Cited by 59
miRNAs in Human Cancer
Zhong, X., Coukos, G., & Zhang, L. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-427-8_21 · Cited by 60
Pediatric primary central nervous system germ cell tumors of different prognosis groups show characteristic miRNome traits and chromosome copy number variations
Wang, H., Wu, Y., Hsieh, J.-Y., Liang, M., Chao, M.-E., Liu, D.-J., Hsu, M., & Wong, T. (2010) · BMC Genomics · doi:10.1186/1471-2164-11-132 · Cited by 58
Shielding the messenger (RNA): microRNA-based anticancer therapies
Sotillo, E., & Thomas‐Tikhonenko, A. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.04.006 · Cited by 59
One Function—Multiple Mechanisms: The Manifold Activities of p53 as a Transcriptional Repressor
Böhlig, L., & Rother, K. (2011) · BioMed Research International · doi:10.1155/2011/464916 · Cited by 58
MicroRNAs in cancer management and their modulation by dietary agents
Karius, T., Schnekenburger, M., Dicato, M. A., & Diederich, M. F. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.02.004 · Cited by 61
MicroRNA‐34b functions as a potential tumor suppressor in endometrial serous adenocarcinoma
Hiroki, E., Suzuki, F., Akahira, J., Nagase, S., Ito, K., Sugawara, J., Miki, Y., Suzuki, T., Sasano, H., & Yaegashi, N. (2011) · International Journal of Cancer · doi:10.1002/ijc.27345 · Cited by 58
Mechanisms of prostate cancer cell survival after inhibition of AR expression
Cohen, M. B., & Rokhlin, O. W. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22022 · Cited by 61
Identification of ionizing radiation-responsive microRNAs in the IM9 human B lymphoblastic cell line
An (2009) · International Journal of Oncology · doi:10.3892/ijo_00000297 · Cited by 59
Tumor suppressor p53 plays a key role in induction of both tristetraprolin and let-7 in human cancer cells
Lee, J., Kim, H. J., Yoon, N. A., Lee, W. H., Min, Y. J., Ko, B. K., Lee, B. J., Lee, A., Cha, H. J., Cho, W. J., et al. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt222 · Cited by 58
Ectopic expression of miR-34a enhances radiosensitivity of non-small cell lung cancer cells, partly by suppressing the LyGDI signaling pathway
Duan, W., Xu, Y., Dong, Y., Cao, L., Tong, J., & Zhou, X. (2013) · Journal of Radiation Research · doi:10.1093/jrr/rrs136 · Cited by 58
Targeting MYC-Regulated miRNAs to Combat Cancer
Frenzel, A., Lovén, J., & Arsenian‐Henriksson, M. (2010) · Genes & Cancer · doi:10.1177/1947601910377488 · Cited by 60
Honokiol abrogates leptin-induced tumor progression by inhibiting Wnt1-MTA1-β-catenin signaling axis in a microRNA-34a dependent manner
Avtanski, D. B., Nagalingam, A., Kuppusamy, P., Bonner, M. Y., Arbiser, J. L., Saxena, N. K., & Sharma, D. (2015) · Oncotarget · doi:10.18632/oncotarget.3844 · Cited by 58
Hepatic Crtc2 controls whole body energy metabolism via a miR-34a-Fgf21 axis
Han, H.-S., Choi, B. H., Kim, J. S., Kang, G. W., & Koo, S. (2017) · Nature Communications · doi:10.1038/s41467-017-01878-6 · Cited by 58
P53 transcriptional activities: A general overview and some thoughts
Millau, J., Bastien, N., & Drouin, R. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.06.002 · Cited by 65
Dissecting miRNA facilitated physiology and function in human breast cancer for therapeutic intervention
Sengupta, D., Deb, M., Kar, S., Pradhan, N., Parbin, S., Kirtana, R., Singh, S. P., Suma, S. G., Niharika, N., Roy, A., et al. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.05.017 · Cited by 57
MiR-34a promotes Fas-mediated cartilage endplate chondrocyte apoptosis by targeting Bcl-2
Chen, H., Wang, J., Hu, B., Wu, X., Chen, Y., Li, R., & Yuan, W. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2420-4 · Cited by 57
Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer
Markou, A. N., Liang, Y., & Lianidou, E. S. (2011) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2011.661 · Cited by 58
Molecular Pathogenesis of Pancreatic Cancer and Clinical Perspectives
Matthaios, D., Zarogoulidis, P., Balgkouranidou, I., Chatzaki, Ε., & Kakolyris, S. (2011) · Oncology · doi:10.1159/000334449 · Cited by 60
Control of microRNA biogenesis and transcription by cell signaling pathways
Saj, A., & Lai, E. C. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.04.010 · Cited by 58
Ordered progression of stage-specific miRNA profiles in the mouse B2 B-cell lineage
Spierings, D. C. J., McGoldrick, D. J., Hamilton-Easton, A. M., Neale, G. A. M., Murchison, E. P., Hannon, G. J., Green, D. R., & Withoff, S. (2011) · Blood · doi:10.1182/blood-2010-10-316034 · Cited by 57
Targeting the Ubiquitin-Mediated Proteasome Degradation of p53 for Cancer Therapy
DeVine, T., & Dai, M. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319180009 · Cited by 58
The Role of microRNAs in the Regulation of Apoptosis in Lung Cancer and Its Application in Cancer Treatment
Othman, N., & Nagoor, N. H. (2014) · BioMed Research International · doi:10.1155/2014/318030 · Cited by 57
Prostate apoptosis response protein 4 sensitizes human colon cancer cells to chemotherapeutic 5-FU through mediation of an NFκB and microRNA network
Wang, B., Kline, C. L. B., Pastor, D. M., Olson, T. L., Frank, B. C., Luu, T. V., Sharma, A. K., Robertson, G. P., Weirauch, M. T., Patierno, S. R., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-98 · Cited by 57
Emergence of miR-34a in radiation therapy
Lacombe, J., & Zenhausern, F. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.11.017 · Cited by 57
Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer
Ramaiah, M. J., Naushad, S. M., Ponnusamy, L., Arivazhagan, G., Sakthiprasad, V., & Pal‐Bhadra, M. (2017) · Gene · doi:10.1016/j.gene.2017.10.018 · Cited by 59
The miR-34 family and its clinical significance in ovarian cancer
Welponer, H., Tsibulak, I., Wieser, V. E., Degasper, C., Shivalingaiah, G., Wenzel, S., Sprung, S., Marth, C., Hackl, H., Fiegl, H., et al. (2020) · Journal of Cancer · doi:10.7150/jca.33831 · Cited by 58
Regulation of Metastasis by microRNAs in Ovarian Cancer
Wang, Y., Kim, S., & Kim, I. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00143 · Cited by 56
A comprehensive study of p53 protein
Patil, M. R., & Bihari, A. (2022) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30331 · Cited by 57
MicroRNA-induced drug resistance in gastric cancer
Dehghanzadeh, R., Jadidi‐Niaragh, F., Gharibi, T., & Yousefi, M. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.08.009 · Cited by 57
Identification of Novel Targets for miR-29a Using miRNA Proteomics
Bargaje, R., Gupta, S., Sarkeshik, A., Park, R., Xu, T., Sarkar, M., Halimani, M., Roy, S. S., Yates, J. R., & Pillai, B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043243 · Cited by 58
Downregulation of miR-34a in breast tumors is not associated with either p53 mutations or promoter hypermethylation while it correlates with metastasis
Javeri, A., Ghaffarpour, M., Taha, M. F., & Houshmand, M. (2013) · Medical Oncology · doi:10.1007/s12032-012-0413-7 · Cited by 56
c-MYC–miRNA circuitry
Tao, J., Zhao, X., & Tao, J. (2014) · Cell Cycle · doi:10.4161/cc.27646 · Cited by 56
Turtle anoxia tolerance: Biochemistry and gene regulation
Krivoruchko, A., & Storey, K. B. (2015) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2015.02.001 · Cited by 58
MicroRNAs and liver cancer associated with iron overload: Therapeutic targets unravelled
Greene, C. M. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i32.5212 · Cited by 58
Hepatic mRNA, microRNA, and miR‐34a‐Target responses in mice after 28 days exposure to doses of benzo(a)pyrene that elicit DNA damage and mutation
Malik, A. I., Williams, A., Lemieux, C. L., White, P. A., & Yauk, C. L. (2011) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20668 · Cited by 57
More epigenetic hits than meets the eye: microRNAs and genes associated with the tumorigenesis of retinoblastoma
Reis, A. H. O., Vargas, F. R., & Lemos, B. (2012) · Frontiers in Genetics · doi:10.3389/fgene.2012.00284 · Cited by 56
Detection of microRNA in Tumor Cells using Exonuclease III and Graphene Oxide-Regulated Signal Amplification
Huang, R.-C., Chiu, W.-J., Li, Y., & Huang, C. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am500534g · Cited by 56
miR-34a is involved in CSE-induced apoptosis of human pulmonary microvascular endothelial cells by targeting Notch-1 receptor protein
Long, Y., Liu, X., Chen, S.-S., Zong, D., Chen, Y., & Chen, P. (2018) · Respiratory Research · doi:10.1186/s12931-018-0722-2 · Cited by 56
MYC and the Art of MicroRNA MaintenancePreprint
Psathas, J. N., & Thomas‐Tikhonenko, A. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a014175 · Cited by 55
The role of noncoding RNAs in epithelial cancer
Agostini, M., Ganini, C., Candi, E., & Melino, G. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-0247-6 · Cited by 56
Circulating miRNAs associated with nonalcoholic fatty liver disease
Atic, A. I., Thiele, M. S., Munk, A., & Dalgaard, L. T. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00253.2022 · Cited by 60
MicroRNA-34a targets FMNL2 and E2F5 and suppresses the progression of colorectal cancer
Lu, G.-F., Sun, Y., An, S., Xin, S., Ren, X., Zhang, D., Wu, P., Liao, W., Ding, Y., & Liang, L. (2015) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2015.06.014 · Cited by 55
MicroRNAs as participants in cytotoxicity of CdTe quantum dots in NIH/3T3 cells
Li, S., Wang, Y., Wang, H., Bai, Y., Liang, G., Wang, Y., Huang, N., & Xiao, Z. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.074 · Cited by 55
Identification of new p53 target microRNAs by bioinformatics and functional analysis
Bisio, A., Sanctis, V. D., Vescovo, V. D., Denti, M. A., Jegga, A. G., Inga, A., & Ciribilli, Y. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-552 · Cited by 56
Perspectives in Cell Cycle Regulation: Lessons from an Anoxic Vertebrate
Biggar, K. K., & Storey, K. B. (2009) · Current Genomics · doi:10.2174/138920209789503905 · Cited by 55
MicroRNA expression patterns in canine mammary cancer show significant differences between metastatic and non-metastatic tumours
Bulkowska, M., Rybicka, A. M., Senses, K. M., Ulewicz, K., Witt, K., Szymanska, J., Taciak, B., Klopfleisch, R., Hellmén, E., Dolka, I., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3751-1 · Cited by 55
MicroRNAs in pancreatic cancer diagnosis and therapy
Słotwiński, R., Lech, G., & Słotwińska, S. M. (2018) · Central European Journal of Immunology · doi:10.5114/ceji.2018.80051 · Cited by 58
MicroRNAs Control Gene Expression
Catalucci, D., Latronico, M. V. G., & Condorelli, G. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1420.004 · Cited by 54
Targeted polymeric nanoparticles for cancer gene therapy
Kim, J., Wilson, D. R., Zamboni, C. G., & Green, J. J. (2015) · Journal of drug targeting · doi:10.3109/1061186x.2015.1048519 · Cited by 57
The p53 tumor suppressor network in cancer and the therapeutic modulation of cell death
Chari, N. S., Pinaire, N. L., Thorpe, L., Medeiros, L. J., Routbort, M. J., & McDonnell, T. J. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0327-9 · Cited by 54
Transferrin-Conjugated SNALPs Encapsulating 2′-O-Methylated miR-34a for the Treatment of Multiple Myeloma
Scognamiglio, I., Martino, M. T. D., Campani, V., Virgilio, A., Galeone, A., Gullà, A., Cantafio, M. E. G., Misso, G., Tagliaferri, P., Tassone, P., et al. (2014) · BioMed Research International · doi:10.1155/2014/217365 · Cited by 54
Regulation of p53 by reversible post-transcriptional and post-translational mechanisms in liver and skeletal muscle of an anoxia tolerant turtle, Trachemys scripta elegans
Zhang, J., Biggar, K. K., & Storey, K. B. (2012) · Gene · doi:10.1016/j.gene.2012.10.049 · Cited by 56
Apoptomirs: small molecules have gained the license to kill
Vecchione, A. M., & Croce, C. M. (2009) · Endocrine Related Cancer · doi:10.1677/erc-09-0163 · Cited by 58
Inhibition of histone deacetylase causes emphysema
Mizuno, S., Yasuo, M., Bogaard, H. J., Kraskauskas, D., Natarajan, R., & Voelkel, N. F. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00207.2010 · Cited by 55
MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma
Li, X., Nie, J., Mei, Q., & Han, W. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i23.5317 · Cited by 54
Post-translational modifications of p53 tumor suppressor: determinants of its functional targets.
Taira, N., & Yoshida, K. (2012) · PubMed · doi:10.14670/hh-27.437 · Cited by 51
Selenite triggers rapid transcriptional activation of p53, and p53-mediated apoptosis in prostate cancer cells: Implication for the treatment of early-stage prostate cancer
Ghosh (2010) · International Journal of Oncology · doi:10.3892/ijo_00000627 · Cited by 52
P53/microRNA-34-induced metabolic regulation: new opportunities in anticancer therapy
Zhang, D., Zheng, J., & Pei, D. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-115 · Cited by 55
MicroRNAs, wild-type and mutant p53: More questions than answers
Jones, M. F., & Lal, A. (2012) · RNA Biology · doi:10.4161/rna.20146 · Cited by 55
MicroRNAs as Regulators of Cisplatin Resistance in Lung Cancer
Chen, Y., Gao, Y., Zhang, K., Li, C., Pan, Y., Chen, J., Wang, R., & Chen, L. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000438548 · Cited by 54
MicroRNA mir-34 provides robustness to environmental stress response via the DAF-16 network in C. elegans
Isik, M., Blackwell, T. K., & Berezikov, E. (2016) · Scientific Reports · doi:10.1038/srep36766 · Cited by 50
microRNAs in Cancer
Cortez, M. A., Ivan, C., Zhou, P., Wu, X., Ivan, M., & Calin, G. A. (2010) · Advances in cancer research · doi:10.1016/b978-0-12-380888-2.00004-2 · Cited by 53
MiR-34a-5p promotes multi-chemoresistance of osteosarcoma through down-regulation of the DLL1 gene
Pu, Y., Zhao, F., Wang, H., & Cai, S. (2017) · Scientific Reports · doi:10.1038/srep44218 · Cited by 53
Colorectal Cancer: From the Genetic Model to Posttranscriptional Regulation by Noncoding RNAs
Lizarbe, M. A., Calle-Espinosa, J., Fernández-Lizarbe, E., Fernández‐Lizarbe, S., Robles-Ramos, M. Á., Olmo, N., & Turnay, J. (2017) · BioMed Research International · doi:10.1155/2017/7354260 · Cited by 55
Potential Role of Exosomes in Mending a Broken Heart: Nanoshuttles Propelling Future Clinical Therapeutics Forward
Dougherty, J. A., Mergaye, M., Kumar, N., Chen, C., Angelos, M. G., & Khan, M. (2017) · Stem Cells International · doi:10.1155/2017/5785436 · Cited by 55
AngiomiRs: MicroRNAs driving angiogenesis in cancer (Review)
Salinas-Vera, Y. M., Marchat, L. A., Gallardo‐Rinc�n, D., Ruíz‐García, E., la Vega, H. A., Echavarr�a‐Zepeda, R., & López‐Camarillo, C. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.4003 · Cited by 53
Up-regulation of Sirt1/miR-149-5p signaling may play a role in resveratrol induced protection against ischemia via p53 in rat brain
Teertam, S. K., Jha, S., & Babu, P. P. (2019) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2019.11.043 · Cited by 53
Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent
Azar, S., Udi, S., Drori, A., Hadar, R., Nemirovski, A., Vemuri, K. V., Miller, M., Sherill-Rofe, D., Arad, Y., Gur‐Wahnon, D., et al. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101087 · Cited by 53

Authors: Chang, T.-C., Wentzel, E. A., Kent, O. A., Ramachandran, K., Mullendore, M., Lee, K. H., Feldmann, G., Yamakuchi, M., Ferlito, M., Lowenstein, C. J., Arking, D. E., Beer, M. A., Maitra, A., & Mendell, J. T.
Affiliations: Johns Hopkins University (US)
Corresponding author: Mendell, Joshua T.
ORCID: Chang, Tsung-Cheng
Kent, Oliver A.
Ramachandran, Kalyani
Lee, Kwang Hyuck
Feldmann, Georg
Yamakuchi, Munekazu
Lowenstein, Charles J.
Arking, Dan E.
Beer, Michael A.
Maitra, Anirban
Mendell, Joshua T.
Venue: Molecular Cell
Publisher: Elsevier BV
Published: 2007-06
Volume: 26
Issue: 5
Pages: 745-752
ISSN: 1097-2765 (ISSN-L)
DOI: 10.1016/j.molcel.2007.05.010
PMC: PMC1939978
OpenAlex: W2038167014
Cited by: 2,010
References: 59
Citations by year: 2026: 23 · 2025: 37 · 2024: 34 · 2023: 47 · 2022: 54 · 2021: 94 · 2020: 84 · 2019: 89 · 2018: 94 · 2017: 116 · 2016: 121 · 2015: 133 · 2014: 186 · 2013: 159 · 2012: 177
FWCI: 45.22
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/open-access/userlicense/1.0/ (vor, 2274 d)
Locations: Molecular Cell (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Rita Allen Foundation
Lustgarten Foundation
Allen Foundation
National Cancer Institute (R01CA113669, R01CA120185)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
Keywords: miR-34a, p53, DNA damage response, apoptosis, gene expression reprogramming, pancreatic cancer, cell cycle regulation, DNA repair, angiogenesis, tumor suppressor
MeSH terms: Base Sequence, DNA Damage, Humans, Pancreatic Neoplasms, Promoter Regions, Genetic, RNA, Neoplasm, Transcriptional Activation, Gene Expression, Tumor Suppressor Protein p53, Apoptosis, MicroRNAs, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Transactivation of miR-34a by p53 Broadly Influences Gene Expression and Promotes Apoptosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks